Loading…
Concord Medical Services Holdings Limited is projected to rise to $5.43 by 2027, a +8% move from its current price of $5.05. CCM is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $4.83 | $5.06 | $5.29 | +0.13% |
| Jul 14 | $4.75 | $5.06 | $5.40 | +0.26% |
| Jul 15 | $4.69 | $5.07 | $5.48 | +0.39% |
| Jul 16 | $4.64 | $5.08 | $5.55 | +0.52% |
| Jul 17 | $4.60 | $5.08 | $5.62 | +0.64% |
| Jul 18 | $4.56 | $5.09 | $5.68 | +0.77% |
| Jul 19 | $4.52 | $5.10 | $5.74 | +0.90% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $4.52 | $5.10 | $5.74 | +0.90% |
| Week 2 | $4.35 | $5.14 | $6.08 | +1.81% |
| Week 3 | $4.22 | $5.19 | $6.37 | +2.73% |
| Week 4 | $4.13 | $5.23 | $6.64 | +3.66% |
| Week 5 | $4.05 | $5.28 | $6.89 | +4.60% |
| Week 6 | $3.98 | $5.33 | $7.13 | +5.54% |
| Week 7 | $3.93 | $5.38 | $7.37 | +6.50% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People’s Republic of China. It operates in two segments, Network and Hospital. The company's services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services.
Its other treatments and diagnostic services comprise positron emission tomography-computed tomography and magnetic resonance imaging scanners. In addition, the company provides clinical support services, such as developing treatment protocols for doctors, and organizing joint diagnosis between doctors in its network and clinical research, and helps to recruit and determine the compensation of doctors and other medical personnel.
Further, it offers radiotherapy and diagnostic equipment leasing, management services, and premium cancer and proton treatment services to hospitals, as well as teleconsultation and medical information technology services; and sells medical equipment. Additionally, the company operates specialty cancer hospitals, which offers radiation, imaging, test laboratory, inpatient, and nursing services. Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, China.
CCM trades as Concord Medical Services Holdings Limited. The current price is $4.88. It has a market capitalization of $21.19M and is ranked 4900.
The price outlook drawn from the year-by-year forecast shows a long-term expansion path, with the average price forecast rising from $4.88 in 2026 to higher levels in later years, and a maximum forecast of $115.13 in 2050. Notably, the avg price climbs to $9.59 by 2030 and to $50.06 by 2050, accompanied by sizable ROI figures through the period.
Overall, the forecast suggests meaningful upside potential over the multi-year horizon, with bullish momentum emerging later in the decade and extending toward 2050, while acknowledging these are estimates rather than guarantees.
A major floor 32.1% below — a decisive break under it would weaken the trend.
The nearest floor, 13.5% below — buyers have tended to step in here.
The nearest ceiling, 8.3% above — a clean break opens room to run.
A major ceiling 20.1% above — clearing it would confirm fresh momentum.
Key CCM support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CCM market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $4.82 | Buy | $4.85 | Buy |
| MA 10 | $4.71 | Buy | $4.78 | Buy |
| MA 20 | $4.75 | Buy | $4.76 | Buy |
| MA 50 | $4.82 | Buy | $4.67 | Buy |
| MA 100 | $4.29 | Buy | $4.54 | Buy |
| MA 200 | $4.51 | Buy | $4.64 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 56.02 | Neutral |
| Stoch RSI (14) | 70.90 | Neutral |
| CCI (20) | 84.42 | Neutral |
| Williams %R (14) | -31.25 | Info |
| MACD (12,26,9) | 0.02 | Buy |
| ROC (12) | 10.75 | Buy |
| Bollinger %B (20,2) | 0.74 | Neutral |
| Stochastic %K (14) | 68.75 | Neutral |
| TRIX (15) | -0.05 | Sell |
| Awesome (5,34) | 0.04 | Buy |
| Ultimate (7,14,28) | 56.58 | Neutral |
| Momentum (10) | 0.64 | Buy |
| Aroon Osc (25) | 8.00 | Buy |
| Hull MA (9) | 4.93 | Buy |
| ADX (14) | 9.38 | Neutral |
| ATR (14) | 0.19 | Info |
The 30-day technical picture is currently bullish. RSI(14) sits at 50, with the 50-day simple moving average at $4.80 and the 200-day simple moving average at $4.52.
Near-term support is identified at $4.37 and resistance at $5.47. The stock has tracked a 30-day price range from $3.61 to $6.60, indicating consolidated movement within this band and potential for a breakout beyond the stated resistance. The setup reflects a modest tilt toward upside in the near term.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $3.43 | $5.05 | $7.49 | 0% | Neutral | |
| $4.07 | $5.43 | $7.81 | +8% | Neutral | |
| $4.35 | $6.11 | $9.29 | +21% | Bullish | |
| $6.18 | $9.04 | $14.35 | +79% | Bullish | |
| $7.11 | $10.81 | $17.77 | +114% | Bullish | |
| $7.51 | $11.82 | $20.04 | +134% | Bullish | |
| $7.75 | $12.59 | $21.95 | +149% | Bullish | |
| $7.65 | $12.83 | $22.92 | +154% | Bullish | |
| $7.72 | $13.35 | $24.38 | +164% | Bullish | |
| $8.67 | $15.44 | $28.80 | +206% | Bullish | |
| $10.74 | $21.97 | $44.62 | +335% | Bullish | |
| $28.06 | $62.35 | $142.96 | +11.3x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $3.43 | $5.05 | $6.09 | +0.00% |
| August 2026 | $4.41 | $5.29 | $6.60 | +4.82% |
| September 2026 | $4.67 | $5.68 | $7.20 | +7.26% |
| October 2026 | $4.58 | $5.63 | $7.24 | -0.90% |
| November 2026 | $4.44 | $5.50 | $7.16 | -2.33% |
| December 2026 | $4.55 | $5.69 | $7.49 | +3.47% |
Click any year to see its month-by-month CCM forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, CCM could reach as high as $7.49, with a base case around $5.05 and support toward $3.43 — roughly 0% from $5.05. Price action looks broadly range-bound.
Expect CCM to range from $4.07 to $7.81 through 2027. The $5.43 average target implies a +8% move from current prices. That is up +8% on the projected 2026 average. A consolidation phase looks the most probable path here.
The CCM price prediction for 2028 points to an average of $6.11 (low $4.35, high $9.29) — a potential gain of +21% on today's $5.05. Momentum favours further upside here.
In 2029, CCM is projected to trade between $6.18 and $14.35, averaging $9.04 — a potential gain of +79% from today's $5.05. That is up +48% on the projected 2028 average. Buyers look set to stay in control over this stretch.
Concord Medical Services Holdings Limited's 2030 outlook centres on $10.81, within a $7.11 to $17.77 range. That is up +20% on the projected 2029 average. That marks a +114% change versus current levels. Momentum favours further upside here.
By 2031, CCM could reach as high as $20.04, with a base case around $11.82 and support toward $7.51 — roughly +134% from $5.05. Buyers look set to stay in control over this stretch.
Expect CCM to range from $7.75 to $21.95 through 2032. The $12.59 average target implies a +149% move from current prices. That is up +7% on the projected 2031 average. Momentum favours further upside here.
The CCM price prediction for 2033 points to an average of $12.83 (low $7.65, high $22.92) — a potential gain of +154% on today's $5.05. Buyers look set to stay in control over this stretch.
In 2034, CCM is projected to trade between $7.72 and $24.38, averaging $13.35 — a potential gain of +164% from today's $5.05. That is up +4% on the projected 2033 average. Momentum favours further upside here.
Concord Medical Services Holdings Limited's 2035 outlook centres on $15.44, within a $8.67 to $28.80 range. That is up +16% on the projected 2034 average. That marks a +206% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, CCM could reach as high as $44.62, with a base case around $21.97 and support toward $10.74 — roughly +335% from $5.05. Momentum favours further upside here.
Expect CCM to range from $28.06 to $142.96 through 2050. The $62.35 average target implies a +11.3x move from current prices. That is up +184% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in CCM today (≈ 198.019802 CCM) could be worth
$12,346.81
+$11,346.81 (+1135%) by 2050 · US Dollar
Based on the average projected CCM price of $62.35 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CCMwould be worth at today's price.
$1,000 invested in CCM on Jul 10, 2025 (≈ 181.818182 CCM) would be worth
$918.18
-$81.82 (-8.2%) today · 0.92× · US Dollar
Based on a CCM entry price of $5.5 vs. today's $5.05.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $4.39 | $1,150.34 | +15.0% |
| 1 month ago | $4.63 | $1,090.71 | +9.1% |
| 3 months ago | $3.95 | $1,278.48 | +27.8% |
| 6 months ago | $4.87 | $1,036.96 | +3.7% |
| 1 year ago | $5.5 | $918.18 | -8.2% |
| All time (5.0y) ago | $28.3 | $178.45 | -82.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CCM forecast.
Our base-case forecast reaches $10.00 around 2030.
Implied market cap at $10.00: $28.15M
The multi-year forecast shows gradual upside beginning with 2026 at an avg of $4.88 and a neutral sentiment, moving to $5.08 (2027) and $5.57 (2028) with continuing neutral sentiment. By 2029, the avg rises to $8.07 with bullish sentiment and a 65.3% ROI, and by 2030 the avg is $9.59 with a 96.4% ROI. The trajectory continues upward through 2031–2035, with 2031 avg $10.44 and ROI 114%, 2032 avg $11.04 and ROI 126.3%, 2033 avg $11.06 and ROI 126.7%, 2034 avg $11.33 and ROI 132.2%, and 2035 avg $12.84 with ROI 163.2%.
Looking further out, 2040 shows an avg of $17.99 and ROI of 268.7%, and by 2050 the avg is $50.06 with a striking 925.8% ROI. The sentiment remains bullish across the longer horizon. These figures are estimates and not guarantees, and actual results may differ due to market and company-specific factors.
Tap a question to reveal the answer.
2030 avg $9.59; min $6.27; max $15.85; ROI 96.4%; sentiment BULLISH.
The forecast shows rising averages and positive ROI in later years, with 2029 avg $8.07 (ROI 65.3%), 2030 avg $9.59 (ROI 96.4%), and 2050 avg $50.06 (ROI 925.8%). These are estimates and not guarantees.
Yes. The 2050 forecast lists an avg of $50.06 and a max of $115.13, indicating potential for values around the $50 level over the long term.
Current price is $4.88 and market cap is $21.19M.
The 30-day range is from $3.61 to $6.60.
Concord Medical Services Holdings Limited Community Discussion
0Share your Concord Medical Services Holdings Limited price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.